Up a level |
(2019) Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial. Complementary Therapies in Medicine. pp. 204-209. ISSN 0965-2299
(2019) The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled clinical trial. Phytotherapy Research. pp. 2369-2377. ISSN 0951-418X
(2018) Nigella sativa and Non-Alcoholic Fatty Liver Disease: A Review of the Current Evidence. Hepatitis Monthly. p. 4. ISSN 1735-143X